Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer
- 1 June 2012
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 160 (2), 394-400
- https://doi.org/10.1016/j.jconrel.2011.12.010
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle SurfacesOnline Journal of Public Health Informatics, 2011
- Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profilesNanomedicine: Nanotechnology, Biology and Medicine, 2009
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- The role of nanoparticle size in hemocompatibilityToxicology, 2009
- Tumour-targeted nanomedicines: principles and practiceBritish Journal of Cancer, 2008
- Method for Analysis of Nanoparticle Hemolytic Properties in VitroNano Letters, 2008
- Liposomes as nanocarriers of lipid-conjugated antitumor drugs melphalan and methotrexateNanotechnologies in Russia, 2008
- The selectin–selectin ligand axis in tumor progressionCancer and Metastasis Reviews, 2008
- Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2007
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003